trending Market Intelligence /marketintelligence/en/news-insights/trending/dnBEGkSu4SzQRJ-eVAz74Q2 content esgSubNav
In This List

Vanc Pharmaceuticals CEO resigns; interim named

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Vanc Pharmaceuticals CEO resigns; interim named

Vanc Pharmaceuticals Inc. CEO Arun Nayyar resigned, effective immediately.

Bob Rai replaced Nayyar on an interim basis. Rai, who has been a director at Vanc since June 2015, is chairman and CEO of Canada Pacific Global Pharmaceuticals.